---
title: "Omega-3 (EPA/DHA) for Longevity: Evidence & Best Supplement | Magellan"
description: "Omega-3 EPA/DHA supports heart, brain, and healthy aging. The human evidence, your Omega-3 Index, dosing, and the best fish oil — with PubMed citations."
url: "https://magellanlongevity.com/omega-3.md"
canonical: "https://magellanlongevity.com/omega-3.html"
html: "https://magellanlongevity.com/omega-3.html"
type: "landing"
section: "Omega-3 (EPA/DHA)"
products: 2
citations: 44
updated: 2026-09-02
author: "Gabriel Radu, DO"
author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765."
publisher: "Magellan Longevity"
content_format: "markdown"
---

# Omega-3 (EPA/DHA): heart, brain, and your Omega-3 Index

[Home](https://magellanlongevity.com/) › Omega-3 (EPA/DHA)

**HTML version:** https://magellanlongevity.com/omega-3.html · **In the Magellan app:** https://magellanlongevity.com/#/cat/1

*Long-chain omega-3s EPA and DHA are among the best-supported nutrients for cardiovascular and brain aging. Here is the evidence, and how to know your Omega-3 Index.*

## Why your Omega-3 Index matters

EPA and DHA are anti-inflammatory fatty acids your body cannot make efficiently. A higher **Omega-3 Index** (the EPA+DHA percentage in red blood cells) tracks with better cardiovascular and brain aging — and you can measure it at home. Oily fish is the best food source; a quality fish-oil or algae supplement closes the gap.

## Omega-3 supplements & testing, graded

Linked to mechanism and PubMed citations.

| Product | Evidence grade | Citations | Typical price | Why it is on this list |
| --- | --- | --- | --- | --- |
| [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md) | Moderate evidence | 22 | $33.75 | Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum triglycerides (roughly 15% at… |
| [Omega-3 Index Test](https://magellanlongevity.com/p/143.md) | Measurement tool | 22 | $54.95 | In prospective cohort studies and pooled analyses spanning dozens of cohorts, higher blood levels of EPA + DHA have… |

## Evidence detail

### Omega-3 EPA/DHA Fish Oil

- **Evidence grade:** Moderate evidence
- **Dose used in studies:** Typical studied range 0.5-4 g/day EPA+DHA; triglyceride and blood-pressure effects are dose-dependent, clearest around 2-3 g/day. Event-reduction evidence is for prescription 4 g/day purified EPA in high-risk patients.
- **What the grade does not say:** Standard over-the-counter doses did not prevent cardiovascular events or cancer in large trials (VITAL, STRENGTH) and meta-analyses, though triglyceride lowering is real. Doses above 1 g/day carry a genuine atrial-fibrillation signal - about 13% higher incident risk in a large cohort of healthy users.

### Omega-3 Index Test

- **Evidence grade:** Measurement tool
- **Dose used in studies:** Once to find your baseline, then again about 4 months after changing oily fish intake or starting a supplement - red cell fatty acids turn over slowly and anything sooner is reading noise. Most people sit around 4-5%; the level associated with lowest risk in the cohort work is roughly 8% or above.
- **What the grade does not say:** This is the one test on the list where the analyte and the method were developed together and both hold up. Pooled across 17 prospective cohorts, higher blood omega-3 levels tracked lower total and cause-specific mortality, the Framingham data point the same way, and the index adds predictive information on top of the pooled cohort equation - and unlike a serum fatty acid, red cell membrane composition is a stable several-month average rather than a snapshot of last night's dinner. Two things to hold in mind anyway - the evidence is observational, and people with a high Omega-3 Index differ from people with a low one in many ways, and the supplement trials designed to test whether raising it changes outcomes have come out mixed rather than clean, so a low number is a reason to eat more oily fish and not proof that a capsule will buy you the associated risk. And the index is a proprietary measure run by the laboratory whose founder developed it and co-authors much of the supporting literature - that is disclosed rather than hidden, but you should know it is not an independently standardised assay with an external reference method behind it.

## Frequently asked questions

### Does omega-3 help you live longer?

Higher omega-3 levels track with lower cardiovascular and all-cause mortality in large cohorts; trial effects are modest but consistent for heart health.

### What is the omega-3 dose?

Many studies use roughly 1–2 g/day of combined EPA+DHA; aim for an Omega-3 Index of 8–12%.

### What is the Omega-3 Index?

It is the percentage of EPA+DHA in your red blood cell membranes — a measurable marker you can test at home.

### Fish oil vs algae oil?

Algae oil is a vegan EPA/DHA source; both raise the Omega-3 Index. Choose a third-party-tested product.

## The research behind these picks

Primary peer-reviewed sources for the products above. Quotes are verbatim from the cited abstract.

### Cited studies

1. **Evidence: anti-inflammatory long-chain PUFAs**
   Cochrane Database Syst Rev 2020 · [PMID 32114706](https://pubmed.ncbi.nlm.nih.gov/32114706/) · [DOI 10.1002/14651858.CD003177.pub5](https://doi.org/10.1002/14651858.CD003177.pub5)

   > increasing omega-3 slightly reduces risk of coronary heart disease mortality and reduces triglycerides

2. **Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis**
   EClinicalMedicine 2021 · [PMID 34505026](https://pubmed.ncbi.nlm.nih.gov/34505026/) · [DOI 10.1016/j.eclinm.2021.100997](https://doi.org/10.1016/j.eclinm.2021.100997)

   > Omega-3 fatty acids reduced cardiovascular mortality and improved cardiovascular outcomes

3. **Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis of Interventional Trials**
   Mayo Clin Proc 2020 · [PMID 32951855](https://pubmed.ncbi.nlm.nih.gov/32951855/) · [DOI 10.1016/j.mayocp.2020.08.034](https://doi.org/10.1016/j.mayocp.2020.08.034)

   > Supplementation with EPA and DHA is an effective lifestyle strategy for cardiovascular disease prevention

4. **Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis**
   Frontiers in Medicine 2025 · [PMID 41267881](https://pubmed.ncbi.nlm.nih.gov/41267881/) · [DOI 10.3389/fmed.2025.1654661](https://doi.org/10.3389/fmed.2025.1654661)

   > This systematic review and meta-analysis found omega-3 supplementation produced a clinically meaningful, time-dependent reduction in chronic pain, particularly at moderate doses.

5. **Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis**
   Archives of Medical Research 2012 · [PMID 22835600](https://pubmed.ncbi.nlm.nih.gov/22835600/) · [DOI 10.1016/j.arcmed.2012.06.011](https://doi.org/10.1016/j.arcmed.2012.06.011)

   > This meta-analysis found omega-3 PUFAs above 2.7 g/day for over 3 months significantly reduced NSAID consumption in rheumatoid arthritis patients.

6. **High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.**
   Adv Nutr 2024 · [PMID 38110000](https://pubmed.ncbi.nlm.nih.gov/38110000/) · [DOI 10.1016/j.advnut.2023.100163](https://doi.org/10.1016/j.advnut.2023.100163)

   > Current pharmacologic prophylactic strategies for migraine have limited efficacy and acceptability, with relatively low response rates of 40% to 50% and limited safety profiles.

7. **Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis.**
   J Orthop Surg Res 2023 · [PMID 37226250](https://pubmed.ncbi.nlm.nih.gov/37226250/) · [DOI 10.1186/s13018-023-03855-w](https://doi.org/10.1186/s13018-023-03855-w)

   > Supplementation of n-3 PUFAs is effective to relieve pain and improve joint function in patients with OA.

8. **Effect of Anti-Inflammatory Diets on Pain in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.**
   Nutrients 2021 · [PMID 34959772](https://pubmed.ncbi.nlm.nih.gov/34959772/) · [DOI 10.3390/nu13124221](https://doi.org/10.3390/nu13124221)

   > The main conclusion is that anti-inflammatory diets resulted in significantly lower pain than ordinary diets (-9.22 mm; 95% CI -14.15 to -4.29; p = 0.0002; 7 RCTs, 326 participants).

9. **Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.**
   N Engl J Med 2018 · [PMID 30415628](https://pubmed.ncbi.nlm.nih.gov/30415628/) · [DOI 10.1056/NEJMoa1812792](https://doi.org/10.1056/NEJMoa1812792)

   > A primary end-point event occurred in 17.2% of the patients in the icosapent ethyl group, as compared with 22.0% of the patients in the placebo group (hazard ratio, 0.75; 95% confidence interval [CI], 0.68 to 0.83; P<0.001)

10. **Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.**
    N Engl J Med 2018 · [PMID 30415637](https://pubmed.ncbi.nlm.nih.gov/30415637/) · [DOI 10.1056/NEJMoa1811403](https://doi.org/10.1056/NEJMoa1811403)

    > Supplementation with n-3 fatty acids did not result in a lower incidence of major cardiovascular events or cancer than placebo.

11. **Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials.**
    J Am Heart Assoc 2023 · [PMID 37264945](https://pubmed.ncbi.nlm.nih.gov/37264945/) · [DOI 10.1161/JAHA.123.029512](https://doi.org/10.1161/JAHA.123.029512)

    > This dose-response meta-analysis demonstrates that combined intake of omega-3 fatty acids near linearly lowers triglyceride and non-high-density lipoprotein cholesterol.

12. **Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.**
    J Am Heart Assoc 2019 · [PMID 31567003](https://pubmed.ncbi.nlm.nih.gov/31567003/) · [DOI 10.1161/JAHA.119.013543](https://doi.org/10.1161/JAHA.119.013543)

    > Marine omega-3 supplementation lowers risk for myocardial infarction, CHD death, total CHD, CVD death, and total CVD, even after exclusion of REDUCE-IT. Risk reductions appeared to be linearly related to marine omega-3 dose.

## Structured data

```json
{"@context":"https://schema.org","@graph":[{"@type":"MedicalWebPage","@id":"https://magellanlongevity.com/omega-3.html#page","url":"https://magellanlongevity.com/omega-3.html","name":"Omega-3 (EPA/DHA): heart, brain, and your Omega-3 Index","description":"Omega-3 EPA/DHA supports heart, brain, and healthy aging. The human evidence, your Omega-3 Index, dosing, and the best fish oil — with PubMed citations.","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/omega-3.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Omega-3 (EPA/DHA)","item":"https://magellanlongevity.com/omega-3.html"}]},{"@type":"FAQPage","@id":"https://magellanlongevity.com/omega-3.html#faq","mainEntity":[{"@type":"Question","name":"Does omega-3 help you live longer?","acceptedAnswer":{"@type":"Answer","text":"Higher omega-3 levels track with lower cardiovascular and all-cause mortality in large cohorts; trial effects are modest but consistent for heart health."}},{"@type":"Question","name":"What is the omega-3 dose?","acceptedAnswer":{"@type":"Answer","text":"Many studies use roughly 1–2 g/day of combined EPA+DHA; aim for an Omega-3 Index of 8–12%."}},{"@type":"Question","name":"What is the Omega-3 Index?","acceptedAnswer":{"@type":"Answer","text":"It is the percentage of EPA+DHA in your red blood cell membranes — a measurable marker you can test at home."}},{"@type":"Question","name":"Fish oil vs algae oil?","acceptedAnswer":{"@type":"Answer","text":"Algae oil is a vegan EPA/DHA source; both raise the Omega-3 Index. Choose a third-party-tested product."}}]},{"@type":"ItemList","@id":"https://magellanlongevity.com/omega-3.html#items","numberOfItems":2,"itemListElement":[{"@type":"ListItem","position":1,"name":"Omega-3 EPA/DHA Fish Oil","url":"https://magellanlongevity.com/p/128.html"},{"@type":"ListItem","position":2,"name":"Omega-3 Index Test","url":"https://magellanlongevity.com/p/143.html"}]}]}
```

## Related on Magellan Longevity

- [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md)
- [Omega-3 Index Test](https://magellanlongevity.com/p/143.md)
- [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md)
- [Senolytics](https://magellanlongevity.com/senolytics.md)
- [Best NMN supplements](https://magellanlongevity.com/best-nmn.md)
- [Urolithin A](https://magellanlongevity.com/urolithin-a.md)
- [Longevity research map](https://magellanlongevity.com/longevity-research-map.html)

## Scope and disclosures

Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication.

Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases.

Reviewed for accuracy by a board-certified physician (DO).